The untold story of sharks is a fascinating tale for any ocean lover, and on April 24, Jess Cramp will come to La Jolla to ...
Tickets currently are $45 for the self-guided tour for Historical Society members and $55 for non-members, and $145 for the Platinum Tour for members and $155 for non-members. Prices for the ...
"I’m John Durant, and I’m the creator of La Jolla Surf, which is a big love letter to surfing in La Jolla," said Durant, reflecting on his passion for the sport and the exhibition that now ...
Here, Scripps scientists are working with drug giant Merck to test a long-acting prodrug injectable of two HIV drugs made by Merck and Gilead which licensed the development candidate in January ...
A new clinical trial from Scripps Research in La Jolla, California ... In that effort, Scripps scientists are working with drug giant Merck to test a long-acting pro-drug injectable of two ...
Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...
On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...
Merck said its “once-in-a-lifetime” drug Keytruda could be subject to price reductions under the Inflation Reduction Act, which would lead to a … ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...
A new clinical trial from Scripps Research in La Jolla aims to make significant gains ... In that effort, Scripps scientists are working with drug giant Merck to test a long-acting prodrug ...
A new clinical trial from Scripps Research in La Jolla aims to make significant gains ... In that effort, Scripps scientists are working with drug giant Merck to test a long-acting prodrug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results